Table 1.
Baseline characteristics of patients.
| Variables | All participants | CAR Tertiles |
P | ||
|---|---|---|---|---|---|
| G1 (≤0.0714) | G2 (0.0714–0.1951) | G3 (≥0.1952) | |||
| Participants | n = 235 | n = 78 | n = 78 | n = 79 | |
| Age, n (%) | 0.773 | ||||
| <70 (year) | 114 (48.5) | 38 (48.7) | 40 (51.3) | 36 (45.6) | |
| ≥70 (year) | 121 (51.5) | 40 (51.3) | 38 (48.7) | 43 (54.4) | |
| Gender, n (%) | 0.040 | ||||
| Female | 135 (57.4) | 52 (66.7) | 46 (59) | 37 (46.8) | |
| Male | 100 (42.6) | 26 (33.3) | 32 (41) | 42 (53.2) | |
| PD duration (year) | 7.0 (4.0, 10.0) | 6.5 (3.2, 10.0) | 7.0 (3.0, 10.0) | 8.0 (4.5, 11.5) | 0.425 |
| mH-Y stage, n (%) | <0.001 | ||||
| 1–3 | 148 (63.0) | 63 (80.8) | 52 (66.7) | 33 (41.8) | |
| 4–5 | 87 (37.0) | 15 (19.2) | 26 (33.3) | 46 (58.2) | |
| MMSE score, n (%) | 0.017 | ||||
| ≤24 | 100 (42.6) | 32 (41) | 25 (32.1) | 43 54.4) | |
| >24 | 135 (57.4) | 46 (59) | 53 (67.9) | 36 (45.6) | |
| NSAIDs use, n (%) | 0.895 | ||||
| No | 195 (83.0) | 64 (82.1) | 66 (84.6) | 65 (82.3) | |
| Yes | 40 (17.0) | 14 (17.9) | 12 (15.4) | 14 (17.7) | |
Abbreviations: mH-Y modified Hoehn and Yahr classification, MMSE Mini-Mental Status Examination, NSAIDs non-steroidal anti-inflammatory drugs.